Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04578938 · ClinicalTrials.gov registry record · Phase 4
Ketamine + Cognitive Training for Suicidality in the Medical Setting
A Phase 4 study of Suicide, Attempted, sponsored by Rebecca Price.
- Active
- Registry status
- Phase 4
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT04578938: Active Phase 4 study of Suicide, Attempted, sponsored by Rebecca Price.
NCT04578938 is a Phase 4 study of Suicide, Attempted that is active but no longer recruiting, run by Rebecca Price. The registered enrollment target is 200 participants, below the 374-participant average among 36 other Suicide, Attempted trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04578938, a Phase 4 study of Suicide, Attempted, is active but no longer recruiting, sponsored by Rebecca Price.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This project seeks to identify the acute and longer-term impact of a single dose of intravenous ketamine among suicidal patients referred for psychiatric consultation/liaison in the medical inpatient setting. The investigators will then test whether ketamine's rapid effects can be extended by introducing helpful information delivered by a computer-based training protocol. This work could ultimately lead to the ability to treat suicidality more efficiently and with broader dissemination by rapidly priming the brain for helpful forms of learning.
Primary Outcome
suicidal ideation/thoughts; range 0-38; high score=worse outcome
Conditions Studied
Interventions
- BEHAVIORAL Sham Training
- BEHAVIORAL Cognitive training
- DRUG Intravenous ketamine
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2021-03-15 |
| Est. Completion | 2026-12-02 |
| Phase | Phase 4 |
What the registry record for NCT04578938 still lists
NCT04578938 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 374-participant average among 36 other Suicide, Attempted trials with a reported enrollment target (47% lower).
The record links to 1 condition, with Suicide, Attempted appearing as the primary indexed condition, and to 3 interventions - of which Sham Training is the first listed.
NCT04578938 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04578938 about?
NCT04578938 is a clinical study titled "Ketamine + Cognitive Training for Suicidality in the Medical Setting". This project seeks to identify the acute and longer-term impact of a single dose of intravenous ketamine among suicidal patients referred for psychiatric consultation/liaison in the medical inpatient setting. The investigators will then test whether ketamine's rapid effects can be extended by introd...
What is the current status of trial NCT04578938?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2021-03-15. Estimated completion is 2026-12-02.
What conditions does trial NCT04578938 study?
This clinical trial studies the following conditions: Suicide, Attempted.
What interventions are being tested in trial NCT04578938?
The interventions under investigation include: Sham Training (BEHAVIORAL), Cognitive training (BEHAVIORAL), Intravenous ketamine (DRUG).
Who is sponsoring clinical trial NCT04578938?
This trial is sponsored by Rebecca Price, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04578938 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide, Attempted
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04578938's enrollment target sits among peer trials
200 15th of 36 higher than 21 of 36 other Suicide, Attempted trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide, Attempted trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Virtual Reality Lethal Means Safety Training
RECRUITING · NA
-
Skills to Enhance Positivity in Suicidal Youth
RECRUITING · NA
-
Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents
RECRUITING · NA
-
Ketamine Treatment of Youth Suicide Attempters
RECRUITING · Phase 3
-
Suicide Intervention for Alaska Native Youth
RECRUITING · NA
-
Enhancing the Effectiveness of Prolonged Exposure Among Suicidal Individuals With PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI